Peter Rhode serves as Executive at HCW Biologics Inc., where they oversee executive responsibilities. Since joining the company, Peter Rhode has executed 5 insider transactions totaling $100.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 11, 2023 involved exercising options for 14,000 shares valued at $2.0K.
Peter Rhode currently holds 77,500 shares of HCW Biologics Inc. (HCWB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Rhode has been a net buyer of HCWB stock. They have purchased $100.0K and sold $0 worth of shares.
Peter Rhode's most recent insider trade was on Dec 11, 2023, when they sold 14,000 shares at $0.14 per share.
Get notified when new Form 4 filings are submitted
| 15,000 |
| $0.14 |
| Discretionary |
| Jan 14, 2022 | HCWB | $360 | Option Exercise | 1,714 | $0.21 | Discretionary |
| Jan 14, 2022 | HCWB | $0 | Option Exercise | 1 | $0.14 | Discretionary |
| Jul 22, 2021 | HCWB | $100.0K | Purchase | 12,500 | $8.00 | Discretionary |